CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

Eli Lilly’s Foundayo delivers diabetes surprise in late-stage study

Phase 3positiveFoundayoPositive
AI Analysis

Summary

Eli Lilly's Foundayo delivered positive results in a late-stage diabetes study, representing a clinical win for the company.

Clinical Trial Data

Phase

3

Primary Endpoint

Met

Importance:7/10
Sentiment:
0.70
late-stage trialdiabetespositive data
Related Companies

Read the original article

Published by yahoo_finance on October 2, 2026 10:33 PM

Read Original